Cargando…

Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post−Myocardial Infarction Patients: The Alpha Omega Cohort Study

INTRODUCTION: Impaired kidney function is a robust risk factor for cardiovascular mortality. Age-related annual kidney function decline of 1.0 ml/min per 1.73 m(2) after age 40 years is doubled in post−myocardial infarction (MI) patients. METHODS: We investigated the impact of the number of cardiova...

Descripción completa

Detalles Bibliográficos
Autores principales: Esmeijer, Kevin, Geleijnse, Johanna M., de Fijter, Johan W., Giltay, Erik J., Kromhout, Daan, Hoogeveen, Ellen K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035162/
https://www.ncbi.nlm.nih.gov/pubmed/29989031
http://dx.doi.org/10.1016/j.ekir.2018.03.005
_version_ 1783337996056002560
author Esmeijer, Kevin
Geleijnse, Johanna M.
de Fijter, Johan W.
Giltay, Erik J.
Kromhout, Daan
Hoogeveen, Ellen K.
author_facet Esmeijer, Kevin
Geleijnse, Johanna M.
de Fijter, Johan W.
Giltay, Erik J.
Kromhout, Daan
Hoogeveen, Ellen K.
author_sort Esmeijer, Kevin
collection PubMed
description INTRODUCTION: Impaired kidney function is a robust risk factor for cardiovascular mortality. Age-related annual kidney function decline of 1.0 ml/min per 1.73 m(2) after age 40 years is doubled in post−myocardial infarction (MI) patients. METHODS: We investigated the impact of the number of cardiovascular risk factors (including unhealthy lifestyle) on annual kidney function decline, in 2426 post-MI patients (60−80 years) of the prospective Alpha Omega Cohort study. Glomerular filtration rate was estimated by serum cystatin C (eGFR(cysC)) and combined creatinine−cystatin C (eGFR(cr-cysC)), using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations from 2012. Data were analyzed by multivariable linear and logistic regression. RESULTS: At baseline, mean (SD) eGFR(cysC) and eGFR(cr-cysC) were 81.5 (19.6) and 78.5 (18.7) ml/min per 1.73 m(2), respectively. Of all patients, 79% were men, 19% had diabetes, 56% had high blood pressure (≥140/90 mm Hg), 16% were current smokers, 56% had high serum low-density lipoprotein (LDL of ≥2.5 mmol/l), and 23% were obese (body mass index of ≥30.0 kg/m(2)). After multivariable adjustment, the additional annual eGFR(cysC) decline (95% confidence interval) was as follows: in patients with versus without diabetes, −0.90 (−1.23 to −0.57) ml/min per 1.73 m(2); in patients with high versus normal blood pressure, −0.50 (−0.76 to −0.24) ml/min per 1.73 m(2); in obese versus nonobese patients, −0.31 (−0.61 to 0.01) ml/min per 1.73 m(2); and in current smokers versus nonsmokers, −0.19 (−0.54 to 0.16) ml/min per 1.73 m(2). High LDL was not associated with accelerated eGFR(cysC) decline. Similar results were obtained with eGFR(cr-cysC). CONCLUSION: In older, stable post-MI patients without cardiovascular risk factors, the annual kidney function decline was −0.90 (−1.16 to −0.65) ml/min per 1.73 m(2). In contrast, in post-MI patients with ≥3 cardiovascular risk factors, the annual kidney function decline was 2.5-fold faster, at −2.37 (−2.85 to −1.89) ml/min per 1.73 m(2).
format Online
Article
Text
id pubmed-6035162
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60351622018-07-09 Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post−Myocardial Infarction Patients: The Alpha Omega Cohort Study Esmeijer, Kevin Geleijnse, Johanna M. de Fijter, Johan W. Giltay, Erik J. Kromhout, Daan Hoogeveen, Ellen K. Kidney Int Rep Clinical Research INTRODUCTION: Impaired kidney function is a robust risk factor for cardiovascular mortality. Age-related annual kidney function decline of 1.0 ml/min per 1.73 m(2) after age 40 years is doubled in post−myocardial infarction (MI) patients. METHODS: We investigated the impact of the number of cardiovascular risk factors (including unhealthy lifestyle) on annual kidney function decline, in 2426 post-MI patients (60−80 years) of the prospective Alpha Omega Cohort study. Glomerular filtration rate was estimated by serum cystatin C (eGFR(cysC)) and combined creatinine−cystatin C (eGFR(cr-cysC)), using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations from 2012. Data were analyzed by multivariable linear and logistic regression. RESULTS: At baseline, mean (SD) eGFR(cysC) and eGFR(cr-cysC) were 81.5 (19.6) and 78.5 (18.7) ml/min per 1.73 m(2), respectively. Of all patients, 79% were men, 19% had diabetes, 56% had high blood pressure (≥140/90 mm Hg), 16% were current smokers, 56% had high serum low-density lipoprotein (LDL of ≥2.5 mmol/l), and 23% were obese (body mass index of ≥30.0 kg/m(2)). After multivariable adjustment, the additional annual eGFR(cysC) decline (95% confidence interval) was as follows: in patients with versus without diabetes, −0.90 (−1.23 to −0.57) ml/min per 1.73 m(2); in patients with high versus normal blood pressure, −0.50 (−0.76 to −0.24) ml/min per 1.73 m(2); in obese versus nonobese patients, −0.31 (−0.61 to 0.01) ml/min per 1.73 m(2); and in current smokers versus nonsmokers, −0.19 (−0.54 to 0.16) ml/min per 1.73 m(2). High LDL was not associated with accelerated eGFR(cysC) decline. Similar results were obtained with eGFR(cr-cysC). CONCLUSION: In older, stable post-MI patients without cardiovascular risk factors, the annual kidney function decline was −0.90 (−1.16 to −0.65) ml/min per 1.73 m(2). In contrast, in post-MI patients with ≥3 cardiovascular risk factors, the annual kidney function decline was 2.5-fold faster, at −2.37 (−2.85 to −1.89) ml/min per 1.73 m(2). Elsevier 2018-03-16 /pmc/articles/PMC6035162/ /pubmed/29989031 http://dx.doi.org/10.1016/j.ekir.2018.03.005 Text en © 2018 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research
Esmeijer, Kevin
Geleijnse, Johanna M.
de Fijter, Johan W.
Giltay, Erik J.
Kromhout, Daan
Hoogeveen, Ellen K.
Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post−Myocardial Infarction Patients: The Alpha Omega Cohort Study
title Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post−Myocardial Infarction Patients: The Alpha Omega Cohort Study
title_full Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post−Myocardial Infarction Patients: The Alpha Omega Cohort Study
title_fullStr Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post−Myocardial Infarction Patients: The Alpha Omega Cohort Study
title_full_unstemmed Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post−Myocardial Infarction Patients: The Alpha Omega Cohort Study
title_short Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post−Myocardial Infarction Patients: The Alpha Omega Cohort Study
title_sort cardiovascular risk factors accelerate kidney function decline in post−myocardial infarction patients: the alpha omega cohort study
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035162/
https://www.ncbi.nlm.nih.gov/pubmed/29989031
http://dx.doi.org/10.1016/j.ekir.2018.03.005
work_keys_str_mv AT esmeijerkevin cardiovascularriskfactorsacceleratekidneyfunctiondeclineinpostmyocardialinfarctionpatientsthealphaomegacohortstudy
AT geleijnsejohannam cardiovascularriskfactorsacceleratekidneyfunctiondeclineinpostmyocardialinfarctionpatientsthealphaomegacohortstudy
AT defijterjohanw cardiovascularriskfactorsacceleratekidneyfunctiondeclineinpostmyocardialinfarctionpatientsthealphaomegacohortstudy
AT giltayerikj cardiovascularriskfactorsacceleratekidneyfunctiondeclineinpostmyocardialinfarctionpatientsthealphaomegacohortstudy
AT kromhoutdaan cardiovascularriskfactorsacceleratekidneyfunctiondeclineinpostmyocardialinfarctionpatientsthealphaomegacohortstudy
AT hoogeveenellenk cardiovascularriskfactorsacceleratekidneyfunctiondeclineinpostmyocardialinfarctionpatientsthealphaomegacohortstudy